23 Nov Oxford secures £17.5 million to lead national AI healthcare programmes
Caristo Diagnostics is proud to have been part of the bid which secured funding for NCIMI in Oxford.
University of Oxford: Innovate UK and industry are to invest more than £17.5 million in the University of Oxford to develop artificial intelligence (AI) healthcare applications to benefit patients. […] Oxford is to be home to one of the five new technology centres across the country, and is also a collaborator in two of the other centres, with local activities integrated within the Big Data Institute. The University of Oxford led centre is the National Consortium of Intelligent Medical Imaging (NCIMI), in which UK Research and Innovation is investing £10 million. NCIMI will also benefit from a further £5 million of funding provided from its commercial partners. The consortium includes 15 NHS hospitals, industry (including GE Healthcare and Alliance Medical), charities, and patient support groups to develop new artificial intelligence tools to help speed up diagnosis of cancer, heart disease, genetic disorders and other conditions.